Conversations
Engineering Human Tissues From Scratch With Frontier Bio’s Eric Bennett
Eric Bennett is the founder and CEO of Frontier Bio, a tissue engineering company developing lab-grown human tissues and organs for medical applications.
Newsletters
DTN 132: Making Semiconductors in Space
Plus: Meteorite smuggling, shoplifter tracking drones, a 6,100 qubit array, MLB approves robot umpires, NASA's new astronaut class, Cloudflare launches a stablecoin, and more.
Newsletters
DTN 131: AI-designed viruses
Plus: Space beer, crackdown on AI companionship, rescuing forgotten satellites, using vapes as web servers, locking nuclear waste in glass logs, and more.
Conversations
The Future of Autonomous Ships with Blue Water Autonomy’s Austin Gray
Austin Gray is a cofounder and chief strategy officer at Blue Water Autonomy, a defense technology company developing autonomous ship-sized vessels for the U.S. Navy and allied forces.
Newsletters
DTN 130: China's Biotech Industry on the Rise
Plus: DIY drones flood the skies, the end of Natcast, Christie's deletes NFT department, self-assembling silicon nanowires, exotic phase of matter on a quantum processor, and more.
Conversations
Japan’s Deep Tech Paradox with Monozukuri Ventures’ Nobuhiro Seki
Nobuhiro Seki is a managing partner at Monozukuri Ventures, a venture capital firm that connects deep tech startups with Japan’s manufacturing ecosystem.
Conversations
From Sci-fi to Sci-fact with AlleyCorp’s Abe Murray
Abe Murray is a general partner at AlleyCorp, an early-stage venture fund that invests across deep tech, healthcare, enterprise software, and consumer tech.
Newsletters
DTN 129: The Space Race is Transforming SoCal's Economy (Again)
Plus: lunar soil bricks, wifi signals measure heart rate, robots walk on water, SpaceX cleared to double Florida launches, Pentagon considers AI-generated propaganda, Taco Bell rethinks AI drive-through, and more.
Conversations
Putting Tech on the Hill with Station DC’s James Barlia
James Barlia is the Executive Director of Station DC, a non-profit connecting innovators, policymakers, and industry leaders in Washington, D.C.
Conversations
Resolving Mismatched Time Horizons with Compound’s Michael Dempsey
Michael Dempsey is a managing partner at Compound, a thesis-driven research-centric venture capital firm investing in deeply technical and scientific areas.
Newsletters
DTN 128: The Nuclear Battery Revival
Plus: Martian metals, Starship success, China's growing brain-computer interface industry, AI-simulated disasters, oxygen made in space, transplanting pig lungs, and more.
Conversations
Building End-to-End Space Communications with Cascade Space’s Jacob Portukalian
Jacob Portukalian is the co-founder and CEO of Cascade Space, a company developing comprehensive communication solutions for spacecraft.